Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Naspers (NPNJn.J)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (RCnt) Price Target (RCnt) Rating
2022-07-154908253760Buy
2022-07-215325270800Buy
2022-10-214143674240Buy
2022-10-273756065280Buy
2022-11-044360060800Buy
2022-11-175159463300Buy
2023-02-226472082000Buy
2023-11-2267918101560Buy
2023-11-3069471102440Buy
2024-05-0675024115940Buy
2024-06-2771148122680Buy
2024-10-1883785142320Buy
2024-12-0385820148920Buy
2025-05-02101513168040Buy

Disclosures

  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.